Bioinformatics Modernization and the Critical Path to Improved Benefit-Risk Assessment of Drugs

MLA

Armando Oliva, et al. “Bioinformatics Modernization and the Critical Path to Improved Benefit-Risk Assessment of Drugs.” Drug Information Journal, vol. 42, May 2008, pp. 273–79. EBSCOhost, https://doi.org/10.1177/009286150804200309.

APA

Armando Oliva, Janet Woodcock, Randy Levin, & Rachel E. Behrman. (2008). Bioinformatics Modernization and the Critical Path to Improved Benefit-Risk Assessment of Drugs. Drug Information Journal, 42, 273–279. https://doi.org/10.1177/009286150804200309

Chicago

Armando Oliva, Janet Woodcock, Randy Levin, and Rachel E. Behrman. 2008. “Bioinformatics Modernization and the Critical Path to Improved Benefit-Risk Assessment of Drugs.” Drug Information Journal 42 (May): 273–79. doi:10.1177/009286150804200309.